Skip to main content
SpringerLink
Log in
Book cover

Maladies rares en médecine d’urgence pp 413–425Cite as

Angiœdème bradykinique

  • Chapter

  • 1153 Accesses

Part of the book series: Références en médecine d’urgence. Collection de la SFMU ((REFERMED))

Résumé

L’angiœdème (AO) bradykinique est une maladie rare qui se caractérise par un œdème sous-cutané ou sous muqueux récidivant, localisé, et transitoire (2 à 5 jours). Il est le plus souvent asymétrique de consistance ferme, ne prend pas le godet. Il est peu ou pas prurigineux mais se traduit par une sensation de tension ou de brûlure. La couleur de la peau est normale, rose ou blanchâtre (fig. 1A et 1B). Il ne s’accompagne pas de fièvre. Il se différencie des œdèmes permanents généralisés (d’origine cardiaque, rénale ou hépatique) et des œdèmes localisés (infectieux, inflammatoires, endocriniens ou vasculaires)

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Fain O, Branellec A, Dubrel M, Javaud N (2011) Les angioedèmes héréditaires. Rev Prat 61: 751–4

    PubMed  Google Scholar 

  2. Banerji A, Clark S, Blanda M, LoVecchio F, Snyder B, Camargo CA Jr (2008) Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department. Ann Allergy Asthma Immunol 100: 327–32

    Article  PubMed  Google Scholar 

  3. Bluestein HM, Hoover TA, Banerji AS, Camargo CA, Jr., Reshef A, Herscu P (2009) Angiotensin-converting enzyme inhibitor-induced angioedema in a community hospital emergency department. Ann Allergy Asthma Immunol 103: 502–7

    Article  PubMed  CAS  Google Scholar 

  4. Zuraw BL (2008) Clinical practice. Hereditary angioedema. N Engl J Med 359: 1027–36

    Article  PubMed  CAS  Google Scholar 

  5. Bouillet L, Boccon-Gibod I, Massot C (2011) Bradykinin mediated angioedema. Rev Med Interne 32(4): 225–31

    Article  PubMed  CAS  Google Scholar 

  6. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351: 1693–7

    Article  PubMed  CAS  Google Scholar 

  7. Nussberger J, Cugno M, Cicardi M (2002) Bradykinin-mediated angioedema. N Engl J Med 347: 621–2

    Article  PubMed  Google Scholar 

  8. Bowen T, Cicardi M, Farkas H et al. (2010) International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 6: 24

    Article  PubMed  Google Scholar 

  9. Longhurst H, Cicardi M (2012) Hereditary angio-oedema. Lancet 379: 474–81

    Article  PubMed  Google Scholar 

  10. Cicardi M, Zingale LC, Pappalardo E, Folcioni A, Agostoni A (2003) Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medicine (Baltimore) 82: 274–81

    Google Scholar 

  11. Fremeaux-Bacchi V, Guinnepain MT, Cacoub P et al. (2002) Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med 113: 194–9

    Article  PubMed  Google Scholar 

  12. Bork K, Hardt J, Schicketanz KH, Ressel N (2003) Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Arch Intern Med 163: 1229–35

    Article  PubMed  Google Scholar 

  13. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W (2000) Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 75: 349–54

    Article  PubMed  CAS  Google Scholar 

  14. Cicardi M, Zanichelli A (2010) Angioedema due to C1 inhibitor deficiency in 2010. Intern Emerg Med 5: 481–6

    Article  PubMed  Google Scholar 

  15. Cichon S, Martin L, Hennies HC et al. (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79: 1098–104

    Article  PubMed  CAS  Google Scholar 

  16. Bork K (2010) Diagnosis and treatment of hereditary angioedema with normal Cl inhibitor. Allergy Asthma Clin Immunol 6: 15

    Article  PubMed  Google Scholar 

  17. Bork K, Barnstedt SE (2003) Laryngeal edema and death from asphyxiation after tooth extraction in four patients with hereditary angioedema. J Am Dent Assoc 134: 1088–94

    PubMed  Google Scholar 

  18. Branellec A, Bouillet L, Javaud N et al. (2012) Acquired C1-Inhibitor Deficiency: 7 Patients Treated with Rituximab. J Clin Immunol 32: 936–41

    Article  PubMed  CAS  Google Scholar 

  19. Kostis JB, Kim HJ, Rusnak J et al. (2005) Incidence and characteristics of angioedema associated with enalapril. Arch Intern Med 165: 1637–42

    Article  PubMed  CAS  Google Scholar 

  20. Miller DR, Oliveria SA, Berlowitz DR, Fincke BG, Stang P, Lillienfeld DE (2008) Angioedema incidence in US veterans initiating angiotensin-converting enzyme inhibitors. Hypertension 51: 1624–30

    Article  PubMed  CAS  Google Scholar 

  21. Pfeffer MA, McMurray JJ, Velazquez EJ et al. (2003) Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349: 1893–906

    Article  PubMed  CAS  Google Scholar 

  22. Haymore BR, Yoon J, Mikita CP, Klote MM, DeZee KJ (2008) Risk of angioedema with angiotensin receptor blockers in patients with prior angioedema associated with angiotensin-converting enzyme inhibitors: a meta-analysis. Ann Allergy Asthma Immunol 101: 495–9

    Article  PubMed  Google Scholar 

  23. Samson S (2007) Hypertension artérielle et facteurs de risque associés. Points de repère 1–8

    Google Scholar 

  24. Ricci P BP, Weill A, Simon D, Tuppin P, Ricordeau P, Allemand H (2010) Treated diabetes: which trends between 2000 and 2009 in France? Bull Epidemiol Hebd 42–43: 425–31

    Google Scholar 

  25. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90: 583–612

    Article  PubMed  CAS  Google Scholar 

  26. Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA (2009) Dipeptidyl peptidase-IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 54: 516–23

    Article  PubMed  CAS  Google Scholar 

  27. Duerr M, Glander P, Diekmann F, Dragun D, Neumayer HH, Budde K (2010) Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipients. Clin J Am Soc Nephrol 5: 703–8

    Article  PubMed  CAS  Google Scholar 

  28. Hill MD, Lye T, Moss H et al. (2003) Hemi-orolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 60: 1525–7

    Article  PubMed  CAS  Google Scholar 

  29. Campbell T, Peckler B, Hackstadt RD, Payor A (2010) ACE inhibitor-induced angioedema of the bowel. Case Report Med 2010: 690–5

    Google Scholar 

  30. Cicardi M, Banerji A, Bracho F et al. (2010) Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363: 532–41

    Article  PubMed  CAS  Google Scholar 

  31. Martinez-Saguer I, Rusicke E, Aygoren-Pursun E, Heller C, Klingebiel T, Kreuz W (2010) Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. Am J Obstet Gynecol 203: 131 e1–7

    Article  PubMed  Google Scholar 

  32. Cicardi M, Zanichelli A (2010) Acquired angioedema. Allergy Asthma Clin Immunol 6: 14

    Article  PubMed  Google Scholar 

  33. Bright P, Dempster J, Longhurst H (2010) Successful treatment of acquired C1 inhibitor deficiency with icatibant. Clin Exp Dermatol 35: 553–4

    Article  PubMed  CAS  Google Scholar 

  34. Bas M, Greve J, Stelter K et al. (2010) Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series. Ann Emerg Med 56: 278–82

    Article  PubMed  Google Scholar 

  35. Nielsen EW, Gramstad S (2006) Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate. Acta Anaesthesiol Scand 50: 120–2

    Article  PubMed  CAS  Google Scholar 

  36. Gelee B, Michel P, Haas R, Boishardy F (2008) Angiotensin-converting enzyme inhibitor-related angioedema: emergency treatment with complement C1 inhibitor concentrate. Rev Med Interne 29: 516–9

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service des urgences, Centre de Référence associé sur les angiœdèmes à kinines (CRéAk), AP-HP, Hôpital Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, Université Paris 13, 93143, Bondy Cedex, France

    N. Javaud

  2. SAMU-SMUR 93, AP-HP, Hôpital Avicenne, Hôpitaux Universitaires Paris Seine-Saint-Denis, Université Paris 13, 93000, Bobigny, France

    N. Javaud

  3. Service de médecine interne, Centre de Référence associé sur les angiœdèmes à kinines (CRéAk), AP-HP, Hôpital Jean Verdier, Hôpitaux Universitaires Paris Seine-Saint-Denis, Université Paris 13, 93143, Bondy Cedex, France

    O. Fain

Authors
  1. N. Javaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. O. Fain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N. Javaud .

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Paris

About this chapter

Cite this chapter

Javaud, N., Fain, O. (2013). Angiœdème bradykinique. In: Maladies rares en médecine d’urgence. Références en médecine d’urgence. Collection de la SFMU. Springer, Paris. https://doi.org/10.1007/978-2-8178-0350-0_25

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0350-0_25

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0349-4

  • Online ISBN: 978-2-8178-0350-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation